MTDH and breast carcinoma: Aberrant DNA methylation is an epigenetic feature of tumors, leading to tumor development and progression by silencing oncogenes and activating oncogenes, so we performed corresponding analysis of the methylation level of Metadherin in breast cancer tissues, expecting its suggestive role in promoting breast carcinogenesis and development.